Snowball logo
logo
OVID_logo

Ovid Therapeutics Inc

$2.23+$0.075Β  (3.48%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
208.41.5027480.3920.5667.2521.583
COGS
-1.3816061.5970.60.30.112
Gross Profit
208.41.5027480.3920.5666.9521.548
Operating Expenses & Income
Operating Income
124.2(55.55)(59.28)(61.88)(42.44)(58.36)
Total Operating Expenses
84.1757.0559.6762.4549.3959.94
R&D Expenses
46.9424.6228.5936.7725.5833.6
Selling General & Admin Expenses
37.2332.4329.5925.6824.1126.05
Earnings from Continuing Operations
Interest Expense
(0.0468)(2.760737)----
Interest Income
--4.93.9--
Income Tax Expense
1.328818(2.760737)0.000005---
Net Income
Net Income
122.8(51.41)(52.34)(26.43)(17.41)(34.49)
Supplemental
EBIT
124.2(55.55)(57.58)(58.38)(17.41)(35.74)
EBITDA
124.4(54.17)(57.01)(57.77)(17.11)(35.66)
In millions of USD, except % and values per 1 share